Three primary documents anchor this review, all preprint-stage (bioRxiv/chemRxiv-style DOIs), plus one older publication whose identity match is uncertain. Conway appears as a senior co-author alongside the Dianne Newman lab (Caltech), holding the Michael and Alice Jung Endowed Chair context in medicinal chemistry at UCLA per funding statements . No citation metrics could be verified β the OpenAlex author query returned a 429 rate-limit error, so h-index/citation counts are unknown and should not be assumed.
The portfolio demonstrates chemical depth (DFT/NBO intramolecular H-bond energetics, cyclic voltammetry), biological systems work (PA14 membrane fractionation), and modern computational biology (protein language models + genome-context augmentation). In the redox-lipophilicity study, reduced pyocyanin was strongly membrane-retained: 2.2 Β΅mol/g in membrane fractions vs 0.03 Β΅mol/g extracellular, with estimated >3 mM intracellular concentration under anoxic conditions .
The NO-tuning paper reports +29 Da nitrosylated adducts with distinct redox signatures (1-OHPhz midpoint β0.39 V splitting into two couples at β0.13/β0.43 V and β0.07/β0.46 V), a >4.5-log P. aeruginosa kill with PYO+NO, and loss of anti-S. aureus activity for PYO-NO .
The ML-CITO paper is the most ambitious: from 14 seed positives it scaled to ~600 balanced training sequences via genome-context mining of 202,601 genomes (317 phenazine producers), achieving leave-one-category-out balanced accuracy ~0.75 (AUPR ~0.81) and 8/10 correct out-of-distribution identifications, validated by a biochemically characterized conjugase .
What would change this assessment: peer-reviewed publication outcomes, verifiable citation metrics, independent replication of the PTC biochemistry and PYO retention, and confirmation of author identity across the portfolio.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.